Pharmacist Interventions: Investigating Current and Emerging Treatment Options for COVID-19

This activity is supported by an educational grant from GlaxoSmithKline.

Pharmacists have essential roles as identifiers, educators, and advocates for patients with or at risk of COVID-19 and related complications. This webinar curriculum series will focus on current management and preventive recommendations from the National Institutes of Health and Infectious Diseases Society of America, as well as other health organizations, regarding the treatment of COVID-19. The emergence of new viral genetic variants has greatly impacted existing knowledge on disease transmission and patient outcomes, and the evolving scope of information has led to continuous updates to treatment guidelines. As additional clinical data become available for treatment options for COVID-19, pharmacists must expand their knowledge of the efficacy and safety of the agents approved or authorized for treatment or prevention of COVID-19 infection as well as agents under investigation. This activity will focus on the importance of outpatient treatment and the role of pharmacists in minimizing the burden of COVID-19 through prompt evaluation and treatment of patients to minimize hospitalizations. The 3 webinars in this series will contextualize the currently recommended treatment guidelines and recent and ongoing studies and publications so pharmacists will be able to improve their clinical decision making and offer recommendations regarding the treatment of COVID-19 to reduce complications for patients. Additional components of this resource center will include an Ask the Expert activity and podcast, which will offer discussion on additional updates regarding the management of COVID-19. Participants who complete all 5 CE activities within this curriculum will receive a certificate of completion acknowledging their commitment to educating and advocating for patients during the COVID-19 pandemic.

CE Activity Curriculum

Track Progress

Due to the evolving nature of COVID-19, information related to this topic is quickly changing. These activities included the most up-to-date information and available data at the time of the development of these webinars, but please continue to stay updated as information related to COVID-19 and associated therapies continues to change.

Additional Resources

Latest news from Pharmacy Times:

Study Assessing Pfizer-BioNTech COVID-19 Vaccine in Children Aged 6 Months to Under 5 Years Will Continue, Assess a Third Dose

Learn More >

Certain Patients With Blood Disorders Do Not Produce Antibodies Following COVID-19 Vaccination

Learn More >

Moderna COVID-19 Vaccine Effective Against Viral Variants, Delta Protection Wanes Over Time

Learn More >

Preliminary Data Suggest GSK, Sanofi COVID-19 Booster Effective Regardless of Initial Vaccine

Learn More >

The Impact of the COVID-19 Pandemic on Pharmacy Learners’ Academic Health

Learn More >